Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MSH2 antibody

This Mouse Monoclonal antibody specifically detects MSH2 in IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7865693
$971.10
Plus shipping costs $50.00
1 mL
Shipping to: United States
Delivery in 6 to 9 Business Days

Quick Overview for MSH2 antibody (ABIN7865693)

Target

See all MSH2 Antibodies
MSH2 (Mismatch Repair Protein 2 (MSH2))

Reactivity

  • 126
  • 51
  • 28
  • 14
  • 10
  • 8
  • 8
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 93
  • 48
Mouse

Clonality

  • 71
  • 70
  • 1
Monoclonal

Conjugate

  • 93
  • 6
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MSH2 antibody is un-conjugated

Application

  • 103
  • 57
  • 44
  • 43
  • 41
  • 18
  • 14
  • 13
  • 13
  • 11
  • 10
  • 4
  • 3
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

IHC410
  • Purpose

    anti-MSH2 mouse monoclonal, IHC410, purified

    Purification

    affinity chromatography

    Immunogen

    Recombinant Human MSH2

    Isotype

    IgG2b
  • Application Notes

    Optional[ICC/IF_dilution]: 1:50-1:200 (microwave treatment recommended)

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Tris pH 7.3-7.7 with 1 % BSA and 0.09 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    store at 2 - 8 °C
  • Target

    MSH2 (Mismatch Repair Protein 2 (MSH2))

    Alternative Name

    MSH2

    Background

    MutS Homolog 2 (MSH2) is a protein involved in the mismatch-repair pathway. This protein is commonly associated with hereditary non-polyposis colorectal cancer, and mutations in this gene are correlated with the development of sporadic colorectal carcinoma. Expression levels of MSH2 are abnormally low in a high percentage of patients with microsatellite instability, as well as endometrial and ovarian cancers. Use of Anti-MSH2 is optimized when paired in an IHC panel with antibodies against MSH6, MLH1, and PMS2. Reports have shown Anti-MSH2 to be useful in the detection of the protein in a number of normal and neoplastic tissues, and for identifying a loss of MSH2 in tumours that are microsatellite-unstable.

    Pathways

    DNA Damage Repair, Production of Molecular Mediator of Immune Response
You are here:
Chat with us!